GnRHas vs gestrinone Percentage change values ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
2 findings from 1 review
GnRHas vs GnRHas in conjunction with calcium‐regulating agents Anterior‐posterior spine ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
1 finding from 1 review
GnRHas vs GnRHas in conjunction with calcium‐regulating agents Lateral spine ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
1 finding from 1 review
No studies included for any outcomes · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relief of pain · patients with pain associated with endometriosis
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · patients with pain associated with endometriosis
1 finding from 1 review
Relief of overall pain ‐ reported as dysmenorrhoea ‐ 6 months · patients with pain associated with endometriosis
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic induration ‐ 6 months · patients with pain associated with endometriosis
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic tenderness ‐ 6 months · patients with pain associated with endometriosis
1 finding from 1 review
No studies included with only low risk of bias · patients with pain associated with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as pelvic pain ‐ 3 months compared with placebo (low certainty).
1 finding from 1 review
Relief of painful symptoms ‐ Dysmenorrhoea · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as dysmenorrhoea ‐ 3 months compared with placebo (low certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as dyspareunia ‐ 3 months · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as dyspareunia ‐ 3 months compared with placebo (low certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic tenderness ‐ 6 months · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as pelvic tenderness scores‐ 3… compared with placebo (low certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic induration ‐ 6 months · women with endometriosis
GnRHas showed no clear difference in relief of overall pain ‐ reported as pelvic induration scores ‐ 3… compared with placebo (low certainty).
1 finding from 1 review
No studies included for any outcomes · patients with pain associated with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relief of overall pain ‐ reported as pelvic tenderness, partly resolved ‐ 6 months · patients with pain associated with endometriosis
It is very uncertain whether gnRHas changes relief of overall pain ‐ reported as pelvic tenderness, partly… compared with danazol (very low certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic tenderness, complete resolved ‐ 6 months · patients with pain associated with endometriosis
It is very uncertain whether gnRHas changes relief of overall pain ‐ reported as pelvic tenderness, complete… compared with danazol (very low certainty).
1 finding from 1 review
Relief of painful symptoms ‐ Dysmenorrhoea · patients with pain associated with endometriosis
GnRHas may leads to higher relief of painful symptoms ‐ Dysmenorrhoea compared with no treatment (low certainty).
1 finding from 1 review
Relief of painful symptoms ‐ pelvic tenderness · patients with pain associated with endometriosis
GnRHas may leads to higher relief of painful symptoms ‐ pelvic tenderness compared with placebo (low certainty).
1 finding from 1 review